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THE ability of the liver to recovcr from ischcmia/rcperfu-
sian (I/R) injury depends on the integrity of thc micro-
circulation. 1 It has been recently reported that endothelin 
(ET) plays a major role in the regulation of hepatic microcir-
culation.2 The aim of this study is to determine whether 
inhibition of the binding of endothelin to its receptors by a 
non-selective (ET 1\' ET B) receptor antagonist. TAK-044" 
can lessen livcr injury after 2 hours of warm ischemia. 
MATERIALS AND METHODS 
Two-hour complete hepatic ischemia was induced in adults female 
beagle dogs by clamping the vena cava (above and below the liver) 
and the portal triad. Splanchnic and inferior systemic venous beds 
were decompressed using veno-venous bypass. TAK-044 (donated 
by Takeda Chemical Industries. Ltd, Osaka, Japan), dissolved in 
normal saline and given to animals at a dose of 5,0 mglkg, was given 
as a continuous intravenous infusion (via a peripheral vein) over 30 
minutes, just before hepatic ischemia (Group 2, n = 5), Control 
animals (Group I, n = 10) received a 30-minute infusion of normal 
saline, 
Serial arterial aspartate aminotransferase (AST), alanine amino-
transferase (ALT). and bile acid (BA) levels and hepatic venous 
immunoreactive endothelin-I (irET-I) levels were determined. 
Intraoperative hepatic tissue blood flow (HTBF) was measured 
serially using a laser-doppler flow meter (ALF21; Advance, Co, 
Ltd, Tokyo, Japan). Post-ischemic liver tissues (wedge biopsies) 
were stained with hematoxylin and eosin for histological analysis. 
Results are presented as the mean ::':: the standard error of the 
mean. Statistical analysis of the results was performed using the 
Log Rank test (for survival), and the Mann-Whitney U test (all 
others). A P value less than .05 was considered significant. 
RESULTS 
Two-week animal survival in Group 2 (100%) was signifi-
cantly better than Group 1 (30%). Peak AST and ALT 
levels in Group 1 were significantly higher than AST and 
AL T levels in Group 2. The AST and AL T of Group 1 livers 
12 hours after reperfusion were 1152 ± 1014 UIL and 
13563 ± 1379 UIL, respectively, while AST and ALT of 
Group 2 livers at 12 hours were 3407 ± 420 UIL and 4228 ± 
1167 UIL, respectively. Bile acid levels in Group 1 increased 
after reperfusion, and peaked at 175 ± 39 mmollL 24 hours 
after reperfusion. On the other hand, bile acid levels in 
Group 2 peaked 58 ± 21 mmollL 1 hour after reperfusion, 
and returned to normal levels 12 hours after reperfusion. 
Neither the infusion of T AK-044 (Group 2), nor the normal 
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saline (Group 1). caused any change in hemodynamics. Reper-
fusion caused a significant hemodynamic change in animals of 
both groups; howevcr, the changc was significantly less pro-
nounced in Group 2 (60% of pre-ischemia MAP) than Group 
I (40% of pre-ischemia MAP). Conversely. peak portal vein 
pressure after reperfusion was significantly higher in Group 
1 (12.7 ± 1.9 mm Hg) than in Group 2 (4.2 :!: 0.9 mm Hg). 
Most importantly, however. hepatic tissue blood flow aftcr 
repcrfusion was significantly better in Group 2 (51.4 ::t:: 
1.6% of normal) than in Group 1 (26.8 ± 1.7%). 
Two hours of complete normothermic hepatic ischemia 
caused a 20-fold increase in irET-llevels in the hepatic venous 
blood of Group I (pre-ischemia: 0.8 ::t:: 0.2 pg/mL vs post-
ischemia: 17.6 ± 6.3 pg/mL). The increase of irET-1 was 
further enhanced by T AK-044 treatment (47.8 ± 10.4 pglmL). 
Histological analysis of post-ischemic liver tissue revealed 
that microthombi formation and heterotopic blood in sinu-
soid were significantly worse in Group 1 than in Group 2. 
DISCUSSION 
The infusion of T AK-044, a nonselective ET NB receptor 
antagonist, before prolonged complete hepatic ischemia 
improved post-reperfusion hemodynamics, hepatic tissue 
blood flow, liver function, and tissue histology. As described 
in other studies,2 our results suggest that endogenous 
endothelin influences hepatic microcirculation, and can 
induce microcirculatory disturbances after ischemia and 
reperfusion. Our results also suggest that the inhibition of 
endothelin binding to its receptors by the non-selective 
ET NB receptor antagonist. T AK-044, provides effective pro-
tection against ischemia and reperfusion injury to the liver. 
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